Showing results (1-10 of 288) with videos related to

Sort By:
Pageof 29
Leukemia|August 15, 2000
Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GMS B Marley, R J Davidson, J M Goldman, et al.
Experimental Hematology|May 17, 2000
The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemiaS B Marley, M W Deininger, R J Davidson, et al.
Bone Marrow Transplantation|April 10, 1999
Optimal timing for processing and cryopreservation of umbilical cord haematopoietic stem cells for clinical transplantationA A Shlebak, S B Marley, I A Roberts, et al.
British Journal of Haematology|March 1, 1996
Kinetics of colony formation by BFU-E grown under different culture conditions in vitroS B Marley, T A Amos, M Y Gordon
British Journal of Haematology|August 12, 1999
Evidence for a continuous decline in haemopoietic cell function from birth: application to evaluating bone marrow failure in childrenS B Marley, J L Lewis, R J Davidson, et al.
Leukemia|December 7, 2007
Subcellular distribution of p210(BCR-ABL) in CML cell lines and primary CD34+ CML cellsH Patel, S B Marley, L Greener, et al.
Leukemia|May 8, 1999
Cell biology of CML cellsM Y Gordon, F Dazzi, S B Marley, et al.
Leukemia Research|October 13, 2001
Progenitor cells from patients with advanced phase chronic myeloid leukaemia respond to STI571 in vitro and in vivoS B Marley, R J Davidson, J L Lewis, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Contact-mediated inhibition of human haematopoietic progenitor cell proliferation may be conferred by stem cell antigen, CD34M Y Gordon, S B Marley, R J Davidson, et al.
The Journal of Clinical Investigation|August 26, 1998
Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GMM Y Gordon, S B Marley, J L Lewis, et al.
Pageof 29